文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.

作者信息

Miettinen Markku, Wang Zeng-Feng, Lasota Jerzy

机构信息

Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, 6825 16th Street, NW, Building 54, Room G090,Washington, DC 20306-6000, USA.

出版信息

Am J Surg Pathol. 2009 Sep;33(9):1401-8. doi: 10.1097/PAS.0b013e3181a90e1a.


DOI:10.1097/PAS.0b013e3181a90e1a
PMID:19606013
Abstract

Gastrointestinal stromal tumors (GISTs), KIT or platelet derived growth factor receptor alpha (PDGFRA) signaling driven mesenchymal tumors of the gastrointestinal (GI)-tract and abdomen, require a precise diagnosis so that the patients may benefit from the newly introduced tyrosine kinase inhibitor drugs. The limitations of the current main tools, KIT immunohistochemistry and KIT/PDGFRA mutation analysis, include lack of KIT expression and mutations in some GISTs. In this study we examined 1168 GISTs of different sites and histologic subtypes, and 672 other tumors and normal tissues for discovered on GIST-1 (DOG1) clone K9, a newly introduced immunohistochemical marker, a chloride channel protein. All GISTs and selected non-GISTs were independently evaluated for KIT. In the GI tract, Cajal cells and gastric surface epithelia were DOG1-positive. The overall sensitivity of DOG1 and KIT in GISTs was nearly identical: 94.4% and 94.7%, and results in GISTs were generally concordant. Gastric spindle cell GISTs was nearly uniformly positive for both markers, whereas DOG1 performed slightly better in gastric epithelioid GISTs that included PDGFRA mutant GISTs. In the intestinal GISTs, KIT was slightly more sensitive than DOG1. Negativity for both DOG1 and KIT was observed in 2.6% of GISTs of GI tract. KIT or PDGFRA mutations were detected in 11/24 DOG1-negative GISTs supporting the diagnosis of GIST. DOG1 expression was also generally present in extragastrointestinal and metastatic GISTs. DOG1 was highly specific for GIST, but exceptional DOG1-positive other mesenchymal tumors included uterine type retroperitoneal leiomyomas, peritoneal leiomyomatosis, and synovial sarcomas (positive in 5/42, 4/17, and 6/37 cases). Leiomyomas colonized by DOG1-positive Cajal cells should not be confused with GISTs. DOG1 positivity was relatively common in esophageal squamous cell and gastric carcinomas, whereas it was rare in colorectal carcinomas. DOG1 should be added into the diagnostic panel evaluating GI and other abdominal tumors, but limitations in its sensitivity and specificity should be recognized.

摘要

相似文献

[1]
DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.

Am J Surg Pathol. 2009-9

[2]
Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.

Am J Surg Pathol. 2009-9

[3]
Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.

Am J Surg Pathol. 2009-3

[4]
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.

Am J Surg Pathol. 2008-2

[5]
DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks.

Am J Clin Pathol. 2011-3

[6]
The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.

Adv Anat Pathol. 2010-5

[7]
Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).

Mod Pathol. 2000-10

[8]
Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.

J Pathol. 2004-4

[9]
KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.

Am J Surg Pathol. 2011-9

[10]
Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.

Pol J Pathol. 2003

引用本文的文献

[1]
An update on gastrointestinal stromal tumors (GISTs) with a focus on extragastrointestinal stromal tumors (EGISTs).

Gastroenterol Rep (Oxf). 2025-7-23

[2]
Mechanism of action and therapeutic value of anoctamin-1 in gastrointestinal cancers.

Front Immunol. 2025-5-6

[3]
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.

Heliyon. 2024-11-22

[4]
New Abdominal Mass After Surgery for Gastrointestinal Stromal Tumor: Desmoid-Type Fibromatosis Difficult to Distinguish from Mesenchymal Tumor - A Case Report.

Int Med Case Rep J. 2024-11-14

[5]
True Mitotic Count Prediction in Gastrointestinal Stromal Tumors: Bayesian Network Model and PROMETheus (Preoperative Mitosis Estimator Tool) Application Development.

J Med Internet Res. 2024-10-22

[6]
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report.

Rev Recent Clin Trials. 2024

[7]
Primary gastrointestinal stromal tumor of the liver: a case report.

Ann Med Surg (Lond). 2024-5-28

[8]
Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines.

Br J Cancer. 2025-1

[9]
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.

Int J Clin Oncol. 2024-6

[10]
Diagnostic Utility of Expression Pattern of S100/Mammaglobin/SOX10/DOG 1 Immunohistochemistry in Differentiation of Secretory and Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.

Indian J Otolaryngol Head Neck Surg. 2024-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索